ConductScience.org, home

Paper24001049

Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.

Draman MS and 11 others. Thyroid, 2013. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy. Papers, record 24001049. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24001049

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.
PubMed
Journal
Thyroid
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.73
iCite
Revised in PubMed
2021-10-21
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Draman MSMohd Shazli
2Grennan-Jones FFiona
3Zhang LLei
4Taylor PNPeter N
5Tun TKTommy Kyaw
6McDermott JJohn
7Moriarty PPaul
8Morris DDaniel
9Lane CCarol
10Sreenan SSeamus
11Dayan CColin
12Ludgate MMarian

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdipocytesMajor topic
AdipogenesisMajor topic
DinoprostMajor topic
Graves OphthalmopathyMajor topic
3T3-L1 Cells
Animals
Cell Proliferation
Fibroblasts
Humans
Lipolysis
Mice

Source PubMed

Download CSV of topics

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19144422Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium.Biochem Biophys Res Commun1997https://conductscience.org/library/papers/9144422PubMed
222107041In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.J Ocul Pharmacol Ther2012https://conductscience.org/library/papers/22107041PubMed
320670089Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature.Cutan Ocul Toxicol2010https://conductscience.org/library/papers/20670089PubMed
48765050Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells.Differentiation1996https://conductscience.org/library/papers/8765050PubMed
517122103Biological effects of thyrotropin receptor activation on human orbital preadipocytes.Invest Ophthalmol Vis Sci2006https://conductscience.org/library/papers/17122103PubMed
622136089Comparison of human ocular distribution of bimatoprost and latanoprost.J Ocul Pharmacol Ther2012https://conductscience.org/library/papers/22136089PubMed
711788681Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy.J Clin Endocrinol Metab2002https://conductscience.org/library/papers/11788681PubMed
812790806Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo.J Mol Endocrinol2003https://conductscience.org/library/papers/12790806PubMed
910782363Management of Graves' ophthalmopathy: reality and perspectives.Endocr Rev2000https://conductscience.org/library/papers/10782363PubMed
107886878The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.Trans Am Ophthalmol Soc1994https://conductscience.org/library/papers/7886878PubMed
118288601Cloning and expression of a cDNA for mouse prostaglandin F receptor.J Biol Chem1994https://conductscience.org/library/papers/8288601PubMed
128300593Cloning and expression of a cDNA for the human prostanoid FP receptor.J Biol Chem1994https://conductscience.org/library/papers/8300593PubMed
1321158579Periorbital fat atrophy - an unfamiliar side effect of prostaglandin analogues.Orbit2010https://conductscience.org/library/papers/21158579PubMed
1419633293Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction.J Biol Chem2009https://conductscience.org/library/papers/19633293PubMed
1518645437Periorbital changes associated with topical bimatoprost.Ophthalmic Plast Reconstr Surg2008https://conductscience.org/library/papers/18645437PubMed
1616888802Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway.J Cell Biochem2007https://conductscience.org/library/papers/16888802PubMed
1711275939Immunosuppressive therapy in patients with thyroid eye disease: an overview of current concepts.Eur J Endocrinol2001https://conductscience.org/library/papers/11275939PubMed
1821331688Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.Jpn J Ophthalmol2011https://conductscience.org/library/papers/21331688PubMed
192327955Activation of inositol phospholipid breakdown by prostaglandin F2 alpha without any stimulation of proliferation in quiescent NIH-3T3 fibroblasts.Biochem J1990https://conductscience.org/library/papers/2327955PubMed
2012519830Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?J Clin Endocrinol Metab2003https://conductscience.org/library/papers/12519830PubMed

See all 36 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
34889904Expression of Endogenous Putative TSH Binding Protein in Orbit.Curr Issues Mol Biol2021https://conductscience.org/library/papers/34889904PubMed
34487739Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.Surv Ophthalmol2022https://conductscience.org/library/papers/34487739PubMed
34473251The Role of Mitochondria-Linked Fatty-Acid Uptake-Driven Adipogenesis in Graves Orbitopathy.Endocrinology2021https://conductscience.org/library/papers/34473251PubMed
33266331Distinctive Features of Orbital Adipose Tissue (OAT) in Graves' Orbitopathy.Int J Mol Sci2020https://conductscience.org/library/papers/33266331PubMed
31889140New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.Nat Rev Endocrinol2020https://conductscience.org/library/papers/31889140PubMed
30551199The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy.Invest Ophthalmol Vis Sci2018https://conductscience.org/library/papers/30551199PubMed
28484500Pingmu Decoction Induces Orbital Preadipocytes Apoptosis In Vitro.Evid Based Complement Alternat Med2017https://conductscience.org/library/papers/28484500PubMed
28369019In Vivo Effects of Retrobulbar Bimatoprost Injection on Orbital Fat.Ophthalmic Plast Reconstr Surg2018https://conductscience.org/library/papers/28369019PubMed
28237084Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.Prostaglandins Leukot Essent Fatty Acids2017https://conductscience.org/library/papers/28237084PubMed
27552406Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells?Invest Ophthalmol Vis Sci2016https://conductscience.org/library/papers/27552406PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24001049

GET https://conductscience.org/api/papers/v1/24001049/references?page=2